- Home
- SGRP vs BCTX Comparison
SGRP vs BCTX Comparison
Compare SGRP & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- BCTX
- Stock Information
- Founded
- SGRP 1967
- BCTX 2014
- Country
- SGRP United States
- BCTX Canada
- Employees
- SGRP N/A
- BCTX N/A
- Industry
- SGRP Business Services
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- SGRP Consumer Discretionary
- BCTX Health Care
- Exchange
- SGRP Nasdaq
- BCTX Nasdaq
- Market Cap
- SGRP 24.5M
- BCTX 23.5M
- IPO Year
- SGRP 1996
- BCTX N/A
- Fundamental
- Price
- SGRP $1.05
- BCTX $3.11
- Analyst Decision
- SGRP
- BCTX Strong Buy
- Analyst Count
- SGRP 0
- BCTX 1
- Target Price
- SGRP N/A
- BCTX $32.00
- AVG Volume (30 Days)
- SGRP 39.5K
- BCTX 359.2K
- Earning Date
- SGRP 08-13-2025
- BCTX 06-16-2025
- Dividend Yield
- SGRP N/A
- BCTX N/A
- EPS Growth
- SGRP N/A
- BCTX N/A
- EPS
- SGRP N/A
- BCTX N/A
- Revenue
- SGRP $196,814,000.00
- BCTX N/A
- Revenue This Year
- SGRP N/A
- BCTX N/A
- Revenue Next Year
- SGRP N/A
- BCTX N/A
- P/E Ratio
- SGRP N/A
- BCTX N/A
- Revenue Growth
- SGRP N/A
- BCTX N/A
- 52 Week Low
- SGRP $1.00
- BCTX $2.78
- 52 Week High
- SGRP $2.48
- BCTX $29.40
- Technical
- Relative Strength Index (RSI)
- SGRP 41.98
- BCTX 44.63
- Support Level
- SGRP $1.03
- BCTX $2.78
- Resistance Level
- SGRP $1.08
- BCTX $3.16
- Average True Range (ATR)
- SGRP 0.04
- BCTX 0.19
- MACD
- SGRP 0.00
- BCTX -0.01
- Stochastic Oscillator
- SGRP 16.67
- BCTX 40.24
About SGRP SPAR Group Inc.
SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.